New drug trial aims to boost energy in cancer patients
NCT ID NCT06075030
First seen Mar 03, 2026 · Last updated Apr 09, 2026 · Updated 5 times
Summary
This study is testing an investigational drug called AND017 to see if it is safe and effective for treating anemia (low red blood cells) in people with cancer who are receiving chemotherapy. The main goal is to see if AND017 can increase hemoglobin levels, which could help reduce fatigue and the need for blood transfusions. The study will involve about 36 participants and will last for 6 weeks of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY INDUCED ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.